MD1469G2 - Method of treatment of the burn shock - Google Patents

Method of treatment of the burn shock

Info

Publication number
MD1469G2
MD1469G2 MD99-0059A MD990059A MD1469G2 MD 1469 G2 MD1469 G2 MD 1469G2 MD 990059 A MD990059 A MD 990059A MD 1469 G2 MD1469 G2 MD 1469G2
Authority
MD
Moldova
Prior art keywords
treatment
burn
day
burn shock
roxatidin
Prior art date
Application number
MD99-0059A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1469F1 (en
Inventor
Anatolie Taran
Vitalie Rafulea
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Spitalul Clinic De Ortopedie Si Traumatologie Al Ministerului Sanatatii Al Republicii Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова, Spitalul Clinic De Ortopedie Si Traumatologie Al Ministerului Sanatatii Al Republicii Moldova filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MD99-0059A priority Critical patent/MD1469G2/en
Publication of MD1469F1 publication Critical patent/MD1469F1/en
Publication of MD1469G2 publication Critical patent/MD1469G2/en

Links

Abstract

The invention relates to the medicine, namely to the surgery and traumatology.The proposed method includes restoration of the internal organs function, carrying out of acupuncture seances and the intravenous administration in 8…12 hours after the burn of 0,02 g of quamatel solution 2…3 times a day and 0,15…0,3 g of roxatidin 2 times a day per os.The result consists in the gastric mucosa protectionand reduction of pain syndrome.
MD99-0059A 1999-02-10 1999-02-10 Method of treatment of the burn shock MD1469G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0059A MD1469G2 (en) 1999-02-10 1999-02-10 Method of treatment of the burn shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0059A MD1469G2 (en) 1999-02-10 1999-02-10 Method of treatment of the burn shock

Publications (2)

Publication Number Publication Date
MD1469F1 MD1469F1 (en) 2000-05-31
MD1469G2 true MD1469G2 (en) 2001-01-31

Family

ID=19739327

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0059A MD1469G2 (en) 1999-02-10 1999-02-10 Method of treatment of the burn shock

Country Status (1)

Country Link
MD (1) MD1469G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD481Z (en) * 2011-08-09 2012-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating I-IIIA-degree burns

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Розин Л. Б, Баткин А. А., Катрушенко Р. Н. Ожоговый шок. Ленинград, Медицина, 1975, с. 167-201. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD481Z (en) * 2011-08-09 2012-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating I-IIIA-degree burns

Also Published As

Publication number Publication date
MD1469F1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
GEP20053715B (en) Prevention and Treatment of Amyloidogenic Disease
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
HUP0100437A2 (en) Therapeutic formulation for administering tolterodine with controlled release
GB0009056D0 (en) Composition comprising free amino acids
CZ176495A3 (en) The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
KR950703951A (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
HUP0102728A2 (en) Methods and transdermal compositions for pain relief
CA2294921A1 (en) Levobupivacaine and its use
RU95101385A (en) Products containing g-csf and tnf-binding protein
NZ507203A (en) Use of dexmedetomidine for ICU sedation
GB9727131D0 (en) Therapeutic agents
SE9902597D0 (en) New use
EP0744176A3 (en) Methods for inhibiting bone loss
MD1469G2 (en) Method of treatment of the burn shock
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
EP1347754A4 (en) Compositions for adhesion prevention
SE0200598D0 (en) Pharmaceutical composition and method of treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and / or ischemic consequences
MD1609F1 (en) Method of the recidivating chronic aphthous stomatitis treatment
MD1568G2 (en) Method of treatment of the burn disease in the burn shock period
RU99108221A (en) METHOD OF ANESTHESIA IN THE POSTOPERATIVE PERIOD
RU94000695A (en) Agent showing antiallergic action
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis
UA28928A (en) Method of purulent-inflammatory desease of soft tissues

Legal Events

Date Code Title Description
PD99 Pending application